Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
<p>Abstract</p> <p>Background</p> <p>Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS...
Main Authors: | Keszthelyi Daniel, Dackus Gwen H, Masclee Gwen M, Kruimel Joanna W, Masclee Ad AM |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-230X/12/121 |
Similar Items
-
Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients
by: J.S. Lasa, et al.
Published: (2015-04-01) -
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
by: Arjun Gandhi, et al.
Published: (2021-01-01) -
Comparison of abdominal bloating severity between irritable bowel syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test
by: J. Lasa, et al.
Published: (2012-04-01) -
Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01) -
Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
by: Xiaojun Zhuang, et al.
Published: (2020-06-01)